Filing Details
- Accession Number:
- 0001140361-14-010093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-28 09:48:12
- Reporting Period:
- 2014-02-26
- Filing Date:
- 2014-02-28
- Accepted Time:
- 2014-02-28 09:48:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1092662 | Chembio Diagnostics Inc. | CEMI | Pharmaceutical Preparations (2834) | 880425691 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1577880 | W Sharon Klugewicz | 3661 Horseblock Road Medford NY 11763 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-26 | 10,000 | $3.50 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Purchased shares in a direct transaction from Richard J. Larkin, Chief Financial Officer of Chembio Diagnostics, Inc.
- As a result of this transaction, the shares will be considered restricted securities pursuant to Rule 144.